4//SEC Filing
Cameron Kevin J 4
Accession 0001114220-18-000060
CIK 0001114220other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:20 PM ET
Size
4.8 KB
Accession
0001114220-18-000060
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Sale
Common Stock
2018-05-29$5.22/sh−1,667$8,702→ 168,333 total
Footnotes (2)
- [F1]Sale of a total of 1,667 shares of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017.
- [F2]Includes 16,666 shares of restricted stock.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeother
Related Parties
1- filerCIK 0001398422
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:20 PM ET
- Size
- 4.8 KB